Ke Wang
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
-
- Respiratory Support and Mechanisms
- Pleural and Pulmonary Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Lung Cancer Treatments and Mutations 16
- Chronic Obstructive Pulmonary Disease (COPD) Research 13
- Respiratory Support and Mechanisms 8
-
- MicroRNA in disease regulation 11
- Cancer, Lipids, and Metabolism 8
- Cancer, Hypoxia, and Metabolism 7
- Co-authors
- Shouming Qin (3 shared papers)Qiang Fu (17 shared papers)Huan‐Zhong Shi (1 shared paper)Xuejun Qin (1 shared paper)Fan Leng (1 shared paper)Lei Chen (1 shared paper)Huiguo Liu (2 shared papers)Kui Liu (1 shared paper)
- Journals
- Scientific Reports (9 papers)PLoS ONE (8 papers)International Immunopharmacology (6 papers)Oncotarget (5 papers)Medicine (5 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ke Wang
275 papers receiving 6.2k citations
Ke Wang's Hit Papers
Peers
Comparison fields: 5 of 184
- Infectious Diseases 758
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 456
- Immunology 645
- Critical Care and Intensive Care Medicine 124
Countries citing papers authored by Ke Wang
This map shows the geographic impact of Ke Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Wang more than expected).
Fields of papers citing papers by Ke Wang
This network shows the impact of papers produced by Ke Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Wang. The network helps show where Ke Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 299 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Hit paper breakdown → | 2020 | 505 |
| 2 | 2012 | 269 | |
| 3 | 2008 | 257 | |
| 4 | 2010 | 164 | |
| 5 | 2020 | 158 | |
| 6 | 2020 | 150 | |
| 7 | 2012 | 113 | |
| 8 | 2016 | 112 | |
| 9 | 2019 | 106 | |
| 10 | 2011 | 102 | |
| 11 | 2019 | 93 | |
| 12 | 2011 | 92 | |
| 13 | 2018 | 83 | |
| 14 | 2008 | 81 | |
| 15 | 2015 | 77 | |
| 16 | 2011 | 76 | |
| 17 | 2017 | 76 | |
| 18 | 2010 | 71 | |
| 19 | 2010 | 66 | |
| 20 | Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial. | 2012 | 66 |
About Ke Wang
Ke Wang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Immunology and Oncology, having authored 299 papers that have together received 6.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), MicroRNA in disease regulation (11 papers), Respiratory Support and Mechanisms (8 papers), Polymer crystallization and properties (8 papers), Cancer, Lipids, and Metabolism (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Infectious Diseases (758 citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (456 citations), Immunology (645 citations) and Critical Care and Intensive Care Medicine (124 citations). Ke Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Shouming Qin, Qiang Fu, Huan‐Zhong Shi, Xuejun Qin, Fan Leng, Lei Chen, Huiguo Liu, Kui Liu, Wei Liu and Yan Deng. Their work appears in journals such as Scientific Reports, PLoS ONE, International Immunopharmacology, Oncotarget and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.